EUVIMEDEUVIMED entdecken
Open Access

Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)

Abhinandan Singla, Gurnoor Kaur, Gurpreet Singh, Shivansh Luthra, Chirag Lodha, Omar Alneser, Mohammed S Alo, Syed S Ali, Muhammad Zulqarnain

Cureus · 25.07.2026

DOI: 10.7759/cureus.113371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 25.07.2026. Verfasst von Abhinandan Singla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Mercy St. Vincent Medical Center, Toledo, USA. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

arrhythmiacardiovascular safetydisproportionality analysisfaersgip receptor agonistglp-1 receptor agonistpharmacovigilancereporting odds ratiosemaglutidetirzepatide

Autor:innen und Institutionen

  • Internal Medicine, Mercy St. Vincent Medical Center, Toledo, USA.
  • Medicine, Government Medical College, Amritsar, IND.
  • Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, USA.
  • Internal Medicine, Henry Ford Macomb Hospital, Detroit, USA.
  • Cardiology, Mercy St. Vincent Medical Center, Toledo, USA.
  • Interventional Cardiology, Mercy St. Vincent Medical Center, Toledo, USA.

Zitieren

APA

Singla, A., Kaur, G., Singh, G., Luthra, S., Lodha, C., Alneser, O., Alo, M. S., Ali, S. S., & Zulqarnain, M. (2026). Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026). Cureus. https://doi.org/10.7759/cureus.113371

Vancouver

Singla A, Kaur G, Singh G, Luthra S, Lodha C, Alneser O, et al. Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026). Cureus. 2026. doi:10.7759/cureus.113371

BibTeX
@article{Singla2026,
  author = {Singla, Abhinandan and Kaur, Gurnoor and Singh, Gurpreet and Luthra, Shivansh and Lodha, Chirag and Alneser, Omar and Alo, Mohammed S and Ali, Syed S and Zulqarnain, Muhammad},
  title = {Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.113371}
}
Kostenlos starten →